Research Article
Prevalence of Posttranscatheter Aortic Valve Implantation Vascular Complications in Real Life
Table 2
Characteristics of transcatheter aortic valve implantation (TAVI) procedures.
| | | Whole population (N = 1055) | Post-TAVI vascular complication group (N = 199) | Post-TAVI without vascular complication group (N = 856) | value |
| | TAVI indication (N, %) | | | | <0.001 | | Severe aortic stenosis | 986 (93.5) | 180 (90.5) | 806 (94.2) | | | Others (aortic regurgitation/prosthetic valve degeneration) | 69 (6.6) | 19 (9.5) | 50 (5.8) | |
| | Right access site (N, %) | 949 (90) | 171 (85.9) | 778 (90.9) | 0.03 |
| | Introducer sheath size (N, %) | | | | | | 14 Fr | 632 (59.9) | 101 (50.8) | 531 (62) | 0.04 | | 16 Fr | 329 (31.2) | 75 (37.7) | 254 (29.7) | | | 18 Fr | 84 (8) | 20 (10.1) | 64 (7.5) | | | 20 Fr | 10 (0.9) | 3 (1.5) | 7 (0.8) | |
| | Valve types (N, %) | | | | 0.17 | | Edwards SAPIEN | 538 (51) | 96 (48.2) | 442 (51.6) | | | CoreValve Evolut | 466 (44.2) | 98 (49.2) | 368 (43) | | | ACURATE | 51 (4.8) | 5 (2.5) | 46 (5.4) | |
| | Valve size (N, %) | | | | 0.7 | | ≤25 | 277 (26.3) | 50 (25.1) | 227 (26.5) | | | ]25–30] | 687 (65.1) | 129 (64.8) | 558 (65.2) | | | >30 | 91 (8.6) | 20 (10.1) | 71 (8.3) | |
| | Procedure duration (N, %) | | | | <0.001 | | ≤60 min | 154 (14.6) | 22 (11.1) | 132 (15.4) | | | ]60–120] min | 864 (81.9) | 159 (79.9) | 705 (82.4) | | | >120 min | 37 (3.5) | 18 (9) | 19 (2.2) | |
|
|
